Achieve Life Sciences ACHV
NASDAQ ACHV
$6.51 0.00 (0.00%)
As of: Oct 21, 2026 · 11:41 AM EDT

Achieve Life Sciences (ACHV) Non-Current Debt (2016 - 2017)

Updated

Analysis

Achieve Life Sciences (ACHV) Non-Current Debt (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 62.48 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 60.50 Bn
10 Achieve Life Sciences 608.75 Mn 421.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 20,000.00
Dec 31, 2016 50,000.00
API Access

Achieve Life Sciences Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ACHV&period=max&api_key=YOUR_API_KEY